Subscribe by Email

About the Blog

The Active Ingredient features expert insights and commentary from leaders of ZS Associates' global pharmaceuticals practice.

Search by Topic

see all

How Pharma Companies Are Engaging Patients as R&D Partners

Posted by Kristyn Feldman on Wed, Nov 08, 2017

Lisa Bance co-wrote this blog post with Kristyn Feldman.

This is the final post in a four-part series examining patient centricity within R&D.

To achieve true patient centricity in drug development, pharmaceutical companies need to follow four main principles: gain empathy for patients, uncover and meet patient needs, connect with patients and, finally, engage patients. By asking for and incorporating trial participant input at every level of R&D, the pharmaceutical industry can start to look at patients as true partners.

Read More

Topics: Big Pharma, Pharma, Patient Engagement, drug development, clinical trials, patient centricity, patient centricity in R&D, online patient network

How Technology and Analytics Are Helping Big Pharma Improve Patient Engagement in R&D

Posted by Kristyn Feldman on Wed, Nov 01, 2017

Lisa Bance co-wrote this blog post with Kristyn Feldman.

This is the third post in a four-part series examining patient centricity within R&D.

As drug development continues to grow more expensive and complex, and as patients expect to be more involved and empowered throughout the healthcare system, pharmaceutical companies are seeing the value in partnering with patients throughout the R&D process. The journey begins with building an understanding of and empathy for today’s patients, and then uncovering and meeting their needs. The third step is to hone in on how you connect with patients to increase the effectiveness of your communications.

Read More

Topics: Big Pharma, Analytics, Patient Engagement, drug development, medical technology, R&D, clinical trials, patient centricity, patient centricity in R&D, meet patient needs

Highlights From ZS’s 2017 European Summit: What Industry Leaders Really Think About Patient Centricity in Pharma

Posted by Giorgio Lentini on Tue, Oct 31, 2017

Robert Selman and Ausrine Vaisvilaite co-wrote this blog post with Giorgio Lentini. 

Are we already patient-centric simply by talking about patients? Do patients define themselves by their medical conditions or by their roles in life as parents, family members or colleagues?

These were just some of the many questions discussed amongst participants at ZS’s European Summit, which took place in Basel, Switzerland, on Oct. 12.

Read More

Topics: Pharma, Pharma Industry, healthcare, Europe, EU, patient centricity, RWE, real-world evidence, patient centricity in R&D, ZS European Summit

How Biopharma Companies Are Working to Uncover and Meet Patient Needs

Posted by Kristyn Feldman on Wed, Oct 25, 2017

Lisa Bance co-wrote this blog post with Kristyn Feldman.

This is the second post in a four-part series examining patient centricity within R&D.

As pharmaceutical companies aim to make their drug development processes more patient-centric, we’ve noted that a formula for success is starting to emerge, and we’ve packaged that formula into our four pillars of patient centricity in R&D. In our last post, we addressed the first pillar: gaining an understanding of and empathy for patients. In this post, we review the second pillar: uncovering and meeting patients’ needs.

Read More

Topics: Pharma, Pharma Industry, Patient Engagement, drug development, co-creation, R&D, patient centricity, patient centricity in R&D, meet patient needs, collaborative communication

How to Develop a Patient-Centric R&D Process

Posted by Kristyn Feldman on Wed, Oct 18, 2017

Lisa Bance co-wrote this blog post with Kristyn Feldman.

This post is the first in a four-part series examining patient centricity within R&D.

The concept of patient centricity within drug development is far from novel, yet many pharmaceutical companies still struggle to put the patient at the center of their R&D efforts. In a recent article, we wrote about the need for pharmaceutical companies to become true partners in patients’ health. In fact, our research shows that engaging patients from the outset could lead to improved patient recruitment and retention and reduce R&D costs and timelines. Here’s the first step—one of four—that companies can take to start moving toward patient-centric drug development.

Read More

Topics: drug development, R&D, clinical trial design, clinical trials, patient centricity, patient voice, patient empathy, patient feedback, patient centricity in R&D

Subscribe to The Active Ingredient
SUBSCRIBE

Get 'THE ACTIVE INGREDIENT' Updates

Subscribe to receive email notifications whenever new blog posts are published.

×